Literature DB >> 10861898

Evidence for major genes influencing pulmonary function in the NHLBI family heart study.

J B Wilk1, L Djousse, D K Arnett, S S Rich, M A Province, S C Hunt, R O Crapo, M Higgins, R H Myers.   

Abstract

Segregation analysis was performed on the pulmonary measures forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and the ratio of FEV1/FVC in 455 randomly ascertained families from the NHLBI Family Heart Study (FHS). Gender specific standardized residuals were used as the phenotypic variable in both familial correlation and segregation analyses. These residuals represented adjustments for the effects of age, age(2), age(3), Body Mass Index (BMI, kg/m(2)), height, the ratio of waist to hip measurements (WHR), the presence of coronary heart disease, smoking history, and pack years for current smokers. Sibling correlations were not different from parent-offspring correlations for all three traits, and heritability estimates for FEV1, FVC, and the FEV1/FVC ratio were 0. 515, 0.540, and 0.449, respectively. Segregation analysis of FEV1, a trait that measures airflow, indicated that a dominant major gene best fits the data, although a residual familial correlation supports the presence of an additional polygenic or common environmental component. For FVC, a trait that measures lung volume, alternative models could not be statistically differentiated, but the transmission probabilities do not support a Mendelian major gene. The best model for FEV1/FVC ratio is a non-Mendelian codominant model, perhaps due to the mixing of the individual underlying distributions influencing airflow and lung volume. These results support the hypothesis that complex relationships exist for lung function traits and that multiple genes and environmental factors influence lung function. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10861898     DOI: 10.1002/1098-2272(200007)19:1<81::AID-GEPI6>3.0.CO;2-8

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  43 in total

1.  The genetic dissection of complex traits in a founder population.

Authors:  C Ober; M Abney; M S McPeek
Journal:  Am J Hum Genet       Date:  2001-10-03       Impact factor: 11.025

Review 2.  Genetic epidemiological approaches in the study of risk factors for cardiovascular disease.

Authors:  Anastasia Iliadou; Harold Snieder
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

3.  Genomewide screen for pulmonary function in 200 families ascertained for asthma.

Authors:  Dirkje S Postma; Deborah A Meyers; Hajo Jongepier; Timothy D Howard; Gerard H Koppelman; Eugene R Bleecker
Journal:  Am J Respir Crit Care Med       Date:  2005-05-18       Impact factor: 21.405

4.  Secreted modular calcium-binding protein 2 haplotypes are associated with pulmonary function.

Authors:  Jemma B Wilk; Alan Herbert; Christina M Shoemaker; Daniel J Gottlieb; Samer Karamohamed
Journal:  Am J Respir Crit Care Med       Date:  2007-01-04       Impact factor: 21.405

Review 5.  Translating the COPD transcriptome: insights into pathogenesis and tools for clinical management.

Authors:  Julie E Zeskind; Marc E Lenburg; Avrum Spira
Journal:  Proc Am Thorac Soc       Date:  2008-12-01

6.  ADAM19 and HTR4 variants and pulmonary function: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study.

Authors:  Stephanie J London; Wei Gao; Sina A Gharib; Dana B Hancock; Jemma B Wilk; John S House; Richard A Gibbs; Donna M Muzny; Thomas Lumley; Nora Franceschini; Kari E North; Bruce M Psaty; Christie L Kovar; Josef Coresh; Yanhua Zhou; Susan R Heckbert; Jennifer A Brody; Alanna C Morrison; Josée Dupuis
Journal:  Circ Cardiovasc Genet       Date:  2014-06

7.  Assessing pleiotropy and mediation in genetic loci associated with chronic obstructive pulmonary disease.

Authors:  Margaret M Parker; Sharon M Lutz; Brian D Hobbs; Robert Busch; MerryLynn N McDonald; Peter J Castaldi; Terri H Beaty; John E Hokanson; Edwin K Silverman; Michael H Cho
Journal:  Genet Epidemiol       Date:  2019-02-11       Impact factor: 2.135

8.  A Genetic Risk Score Associated with Chronic Obstructive Pulmonary Disease Susceptibility and Lung Structure on Computed Tomography.

Authors:  Elizabeth C Oelsner; Victor E Ortega; Benjamin M Smith; Jennifer N Nguyen; Ani W Manichaikul; Eric A Hoffman; Xiuqing Guo; Kent D Taylor; Prescott G Woodruff; David J Couper; Nadia N Hansel; Fernando J Martinez; Robert Paine; Meilan K Han; Christopher Cooper; Mark T Dransfield; Gerard Criner; Jerry A Krishnan; Russell Bowler; Eugene R Bleecker; Stephen Peters; Stephen S Rich; Deborah A Meyers; Jerome I Rotter; R Graham Barr
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

9.  Genetic variation in antioxidant enzymes and lung function.

Authors:  Amy R Bentley; Stephen B Kritchevsky; Tamara B Harris; Anne B Newman; Douglas C Bauer; Bernd Meibohm; Andrew G Clark; Patricia A Cassano
Journal:  Free Radic Biol Med       Date:  2012-03-01       Impact factor: 7.376

Review 10.  Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction.

Authors:  A J Sandford; E K Silverman
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.